Auxilium Pharmaceuticals, Inc.

Who: Endo International/BioSpecifics Technologies What: The companies agree to a deal in which BioSpecifics will become a subsidiary of Endo, giving the latter all rights to injected collagenase dr

Complex generic drug sponsors now can track the US Food and Drug Administration's plans for new and revised product-specific guidances and potentially avoid development or application assessment setba

Complex generic drug sponsors now can track the US Food and Drug Administration's plans for new and revised product-specific guidances and potentially avoid development or application assessment setba

The US Food and Drug Administration got right back into the novel drug approval game after a week off, giving its go-ahead to Ardelyx Inc. 's Ibsrela (tenapanor) for the treatment of irritable bowel